Current
$12B
5-Year Average
$17.6B
All-Time High
$24.9B
All-Time Low
$6.66M
Market cap daily chart for Insulet (PODD)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Insulet (PODD) from 2017 to 2026
Latest: -41.4%
Market Cap history table for Insulet (PODD) from 2007 to 2026
| 2026 | $12B | -41.4% | -$8.46B | ||
| 2025 | $20.4B | +5.9% | +$1.14B | ||
| 2024 | $19.3B | +20.7% | +$3.31B | ||
| 2023 | $16B | -22.4% | -$4.6B | ||
| 2022 | $20.6B | +12.8% | +$2.33B | ||
| 2021 | $18.2B | +8.2% | +$1.39B | ||
| 2020 | $16.9B | +58.0% | +$6.19B | ||
| 2019 | $10.7B | +120.4% | +$5.83B | ||
| 2018 | $4.84B | +20.9% | +$837M | ||
| 2017 | $4B | +85.5% | +$1.85B | ||
| 2016 | $2.16B | +0.5% | +$10.2M | ||
| 2015 | $2.15B | -16.2% | -$415M | ||
| 2014 | $2.56B | +27.9% | +$558M | ||
| 2013 | $2B | +97.0% | +$987M | ||
| 2012 | $1.02B | +15.7% | +$138M | ||
| 2011 | $879M | +43.2% | +$265M | ||
| 2010 | $614M | +44.6% | +$189M | ||
| 2009 | $425M | +99.2% | +$211M | ||
| 2008 | $213M | -45.6% | -$179M | ||
| 2007 | $392M | — | — |
- 2026$12B-41.4%
- 2025$20.4B+5.9%
- 2024$19.3B+20.7%
- 2023$16B-22.4%
- 2022$20.6B+12.8%
- 2021$18.2B+8.2%
- 2020$16.9B+58.0%
- 2019$10.7B+120.4%
- 2018$4.84B+20.9%
- 2017$4B+85.5%
- 2016$2.16B+0.5%
- 2015$2.15B-16.2%
- 2014$2.56B+27.9%
- 2013$2B+97.0%
- 2012$1.02B+15.7%
- 2011$879M+43.2%
- 2010$614M+44.6%
- 2009$425M+99.2%
- 2008$213M-45.6%
- 2007$392M—
Market Cap values are taken from Insulet's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Insulet (PODD)
According to Insulet's latest reported financial statements, the company's latest reported market cap is $14.7B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Insulet (PODD) market cap is $12B – plunged 41.4% year-over-year.
Through 2021–2026 (5 years), Insulet market cap delivered a -8.1% annualised rate; with a net decline across the window.
Between 2022 and 2026, Insulet market cap plunged 41.8%, falling from $20.6B to $12B.
The record annual market cap stands at $20.6B, reached in 2022; the historical low of $213M was recorded in 2008.
Insulet Market Cap by Year
Insulet Market Cap 2026: $12B
2026's market cap for Insulet came in at $12B, plunged 41.4% below 2025.
Insulet Market Cap 2025: $20.4B
Insulet posted market cap of $20.4B in 2025, grew 5.9% from 2024.
Insulet Market Cap 2024: $19.3B
In 2024, Insulet reported market cap of $19.3B, grew 20.7% from 2023.
Insulet Market Cap 2023: $16B
Insulet market cap in 2023 was $16B, declined 22.4% below 2022.
Insulet Market Cap 2022: $20.6B
Insulet market cap in 2022 was $20.6B.
See more financial history for Insulet (PODD).
Sector peers by Market Cap
Healthcare peers of Insulet (PODD), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on PODD
Market Cap — 10 rounds, every one of them PODD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.